These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34684841)

  • 1. The Influence of Antitumor Unsymmetrical Bisacridines on 3D Cancer Spheroids Growth and Viability.
    Kulesza J; Pawłowska M; Augustin E
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular Effects of Selected Unsymmetrical Bisacridines on the Multicellular Tumor Spheroids of HCT116 Colon and A549 Lung Cancer Cells in Comparison to Monolayer Cultures.
    Kulesza J; Paluszkiewicz E; Augustin E
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development.
    Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC
    PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
    Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
    Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D Models of the NCI60 Cell Lines for Screening Oncology Compounds.
    Selby M; Delosh R; Laudeman J; Ogle C; Reinhart R; Silvers T; Lawrence S; Kinders R; Parchment R; Teicher BA; Evans DM
    SLAS Discov; 2017 Jun; 22(5):473-483. PubMed ID: 28288283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro.
    Akasov R; Zaytseva-Zotova D; Burov S; Leko M; Dontenwill M; Chiper M; Vandamme T; Markvicheva E
    Int J Pharm; 2016 Jun; 506(1-2):148-57. PubMed ID: 27107900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Unsymmetrical Bisacridine Derivatives Noncovalently Attached to Quaternary Quantum Dots Improve Cancer Therapy by Enhancing Cytotoxicity toward Cancer Cells and Protecting Normal Cells.
    Pilch J; Matysiak-Brynda E; Kowalczyk A; Bujak P; Mazerska Z; Nowicka AM; Augustin E
    ACS Appl Mater Interfaces; 2020 Apr; 12(15):17276-17289. PubMed ID: 32208730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles.
    Tidwell TR; Røsland G; Tronstad KJ; Søreide K; Hagland HR
    Cancer Med; 2024 Jun; 13(11):e7318. PubMed ID: 38872378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
    Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
    SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
    Karlsson H; Fryknäs M; Larsson R; Nygren P
    Exp Cell Res; 2012 Aug; 318(13):1577-85. PubMed ID: 22487097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
    Howes AL; Richardson RD; Finlay D; Vuori K
    PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc Protein Level Affected by Unsymmetrical Bisacridines Influences Apoptosis and Senescence Induced in HCT116 Colorectal and H460 Lung Cancer Cells.
    Pawłowska M; Kulesza J; Augustin E
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays.
    Tofani LB; Abriata JP; Luiz MT; Marchetti JM; Swiech K
    Biotechnol Prog; 2020 Nov; 36(6):e3034. PubMed ID: 32519461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
    Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
    Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids.
    Madoux F; Tanner A; Vessels M; Willetts L; Hou S; Scampavia L; Spicer TP
    SLAS Discov; 2017 Jun; 22(5):516-524. PubMed ID: 28346088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids.
    Herrmann R; Fayad W; Schwarz S; Berndtsson M; Linder S
    J Biomol Screen; 2008 Jan; 13(1):1-8. PubMed ID: 18040052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
    Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
    Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres.
    Ivanov DP; Parker TL; Walker DA; Alexander C; Ashford MB; Gellert PR; Garnett MC
    PLoS One; 2014; 9(8):e103817. PubMed ID: 25119185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three dimensional spheroid cell culture for nanoparticle safety testing.
    Sambale F; Lavrentieva A; Stahl F; Blume C; Stiesch M; Kasper C; Bahnemann D; Scheper T
    J Biotechnol; 2015 Jul; 205():120-9. PubMed ID: 25595712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.
    LaBonia GJ; Ludwig KR; Mousseau CB; Hummon AB
    Anal Chem; 2018 Jan; 90(2):1423-1430. PubMed ID: 29227110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.